🇺🇸 Batroxobin combined with low molecular weight heparin in United States

Batroxobin combined with low molecular weight heparin (Batroxobin combined with low molecular weight heparin) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Batroxobin combined with low molecular weight heparin in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Batroxobin combined with low molecular weight heparin approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Batroxobin combined with low molecular weight heparin in United States?

Capital Medical University is the originator. The local marketing authorisation holder may differ — check the official source linked above.